Clinical Trial Update: Y90 Radiation Segmentectomy vs SBRT for HCC [NA]

View source ↗

Summary

A terminated clinical trial comparing Y90 radiation segmentectomy versus SBRT for hepatocellular carcinoma has posted results in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Indiana University | Conditions: Hepatocellular Carcinoma (HCC) | NA | Status: TERMINATED | Results posted: 2023-10-25